Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap.

Products

• Abstral, for the treatment of breakthrough cancer pain. It was approved in 2008 in Europe and for marketing in United States by the FDA in 2011.
• Edluar, for the treatment of short-term insomnia. FDA approved in 2009.
• Zubsolv a dissolvable tablet which combines the drugs buprenorphine and naloxone and treats opioid dependency and addiction. FDA approved in July 2013. Launched in the United States in September 2013